236 related articles for article (PubMed ID: 11778664)
21. DMPS-arsenic challenge test. I: Increased urinary excretion of monomethylarsonic acid in humans given dimercaptopropane sulfonate.
Aposhian HV; Arroyo A; Cebrian ME; del Razo LM; Hurlbut KM; Dart RC; Gonzalez-Ramirez D; Kreppel H; Speisky H; Smith A; Gonsebatt ME; Ostrosky-Wegman P; Aposhian MM
J Pharmacol Exp Ther; 1997 Jul; 282(1):192-200. PubMed ID: 9223554
[TBL] [Abstract][Full Text] [Related]
22. Therapeutic potential of monoisoamyl and monomethyl esters of meso 2,3-dimercaptosuccinic acid in gallium arsenide intoxicated rats.
Flora SJ; Mehta A; Rao PV; Kannan GM; Bhaskar AS; Dube SN; Pant BP
Toxicology; 2004 Feb; 195(2-3):127-46. PubMed ID: 14751669
[TBL] [Abstract][Full Text] [Related]
23. Association of respiratory complications and elevated serum immunoglobulins with drinking water arsenic toxicity in human.
Islam LN; Nabi AH; Rahman MM; Zahid MS
J Environ Sci Health A Tox Hazard Subst Environ Eng; 2007 Oct; 42(12):1807-14. PubMed ID: 17952781
[TBL] [Abstract][Full Text] [Related]
24. The role of chelation in the treatment of arsenic and mercury poisoning.
Kosnett MJ
J Med Toxicol; 2013 Dec; 9(4):347-54. PubMed ID: 24178900
[TBL] [Abstract][Full Text] [Related]
25. Electroanalytical and isothermal calorimetric study of As(III) complexation by the metal poisoning remediators, 2,3-dimercapto-1-propanesulfonate and meso-2,3-dimercaptosuccinic acid.
Cavanillas S; Chekmeneva E; Ariño C; Díaz-Cruz JM; Esteban M
Anal Chim Acta; 2012 Oct; 746():47-52. PubMed ID: 22975179
[TBL] [Abstract][Full Text] [Related]
26. Response of arsenic-induced oxidative stress, DNA damage, and metal imbalance to combined administration of DMSA and monoisoamyl-DMSA during chronic arsenic poisoning in rats.
Bhadauria S; Flora SJ
Cell Biol Toxicol; 2007 Mar; 23(2):91-104. PubMed ID: 17086449
[TBL] [Abstract][Full Text] [Related]
27. Reversal of arsenic-induced hepatic apoptosis with combined administration of DMSA and its analogues in guinea pigs: role of glutathione and linked enzymes.
Mishra D; Mehta A; Flora SJ
Chem Res Toxicol; 2008 Feb; 21(2):400-7. PubMed ID: 18163546
[TBL] [Abstract][Full Text] [Related]
28. Effects of 2,3-dimercapto-1-propanesulfonic acid (DMPS) on methylmercury-induced locomotor deficits and cerebellar toxicity in mice.
Carvalho MC; Franco JL; Ghizoni H; Kobus K; Nazari EM; Rocha JB; Nogueira CW; Dafre AL; Müller YM; Farina M
Toxicology; 2007 Oct; 239(3):195-203. PubMed ID: 17703864
[TBL] [Abstract][Full Text] [Related]
29. Systemic manifestations in chronic arsenic toxicity in absence of skin lesions in West Bengal.
Majumdar KK; Guha Mazumder DN; Ghose N; Ghose A; Lahiri S
Indian J Med Res; 2009 Jan; 129(1):75-82. PubMed ID: 19287062
[TBL] [Abstract][Full Text] [Related]
30. Clinical efficacy and safety of chelation treatment with typical penicillamine in cross combination with DMPS repeatedly for Wilson's disease.
Xu SQ; Li XF; Zhu HY; Liu Y; Fang F; Chen L
J Huazhong Univ Sci Technolog Med Sci; 2013 Oct; 33(5):743-747. PubMed ID: 24142730
[TBL] [Abstract][Full Text] [Related]
31. Intravenous injection of metallic mercury: case report and course of mercury during chelation therapy with DMPS.
Vallant B; Deutsch J; Muntean M; Goessler W
Clin Toxicol (Phila); 2008 Jul; 46(6):566-9. PubMed ID: 18584372
[TBL] [Abstract][Full Text] [Related]
32. Evaluation of biochemical changes in chronic arsenic poisoning among Bangladeshi patients.
Nabi AH; Rahman MM; Islam LN
Int J Environ Res Public Health; 2005 Dec; 2(3-4):385-93. PubMed ID: 16819093
[TBL] [Abstract][Full Text] [Related]
33. Arsenic contamination in drinking water and skin manifestations in lowland Nepal: the first community-based survey.
Maharjan M; Watanabe C; Ahmad SA; Ohtsuka R
Am J Trop Med Hyg; 2005 Aug; 73(2):477-9. PubMed ID: 16103627
[TBL] [Abstract][Full Text] [Related]
34. Survival without peripheral neuropathy after massive acute arsenic poisoning: Treated by 2,3-dimercaptopropane-1-sulphonate.
Lu PH; Tseng JC; Chen CK; Chen CH
J Clin Pharm Ther; 2017 Aug; 42(4):506-508. PubMed ID: 28547870
[TBL] [Abstract][Full Text] [Related]
35. Increased urinary excretion of carnitine and acylcarnitine by mercuric chloride is reversed by 2,3-dimercapto-1-propanesulfonic acid in rats.
Al-Madani WA; Siddiqi NJ; Alhomida AS; Khan HA; Arif IA; Kishore U
Int J Toxicol; 2010; 29(3):313-7. PubMed ID: 20448264
[TBL] [Abstract][Full Text] [Related]
36. Optical isomers of 2,3-dimercapto-1-propanesulfonate: antidotal activity, in vitro and in vivo, against sodium arsenite.
Hsu CA; Aposhian HV; Heydolph S; Parr W
J Pharmacol Exp Ther; 1983 Feb; 224(2):314-8. PubMed ID: 6687396
[TBL] [Abstract][Full Text] [Related]
37. Severe iatrogenic bismuth poisoning with bismuth iodoform paraffin paste treated with DMPS chelation.
Ovaska H; Wood DM; House I; Dargan PI; Jones AL; Murray S
Clin Toxicol (Phila); 2008 Nov; 46(9):855-7. PubMed ID: 19003595
[TBL] [Abstract][Full Text] [Related]
38. Quantitative evaluation of urinary porphyrins as a measure of kidney mercury content and mercury body burden during prolonged methylmercury exposure in rats.
Pingree SD; Simmonds PL; Rummel KT; Woods JS
Toxicol Sci; 2001 Jun; 61(2):234-40. PubMed ID: 11353132
[TBL] [Abstract][Full Text] [Related]
39. The Mt. Diwata study on the Philippines 2000-treatment of mercury intoxicated inhabitants of a gold mining area with DMPS (2,3-dimercapto-1-propane-sulfonic acid, Dimaval).
Böse-O'Reilly S; Drasch G; Beinhoff C; Maydl S; Vosko MR; Roider G; Dzaja D
Sci Total Environ; 2003 May; 307(1-3):71-82. PubMed ID: 12711426
[TBL] [Abstract][Full Text] [Related]
40. Chronic arsenic toxicity & human health.
Guha Mazumder DN
Indian J Med Res; 2008 Oct; 128(4):436-47. PubMed ID: 19106439
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
